ArticleJournal of clinical medicine research2025
Prevalence of Anxiety and Depressive Disorders Among Patients Diagnosed With Inflammatory Bowel Disease.
Article in Journal of clinical medicine research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Abbreviated non-contrast magnetic resonance enterography for Crohn's disease: a reliability study.La Radiologia medica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammatory bowel disease (IBD) is linked to high risks of depression and anxiety. Stigma, limited mental health awareness, and barriers to access continue to contribute to underdiagnosis in Saudi Arabia. This study aimed to determine the prevalence of depression and anxiety among IBD patients, identify related risk factors, and assess barriers to mental health treatment. Methods: A cross-sectional study including 92 IBD patients from gastroenterology clinics at King Faisal and Al-Noor hospitals was conducted. Data were collected through face-to-face, phone interviews, and an online Arabic questionnaire assessing sociodemographic, IBD-related factors, and mental health information using Patient Health Questionnaire-2 (PHQ-2) and Generalized Anxiety Disorder-7 (GAD-7). Analysis employed Chi-square, Fisher's exact, and logistic regression model to determine associations. Results: Among 92 patients, 15.2% had symptoms of anxiety, depression, or both. Screening detected 19.6% with depressive symptoms (PHQ-2) and 46.7% with anxiety symptoms (GAD-7), with 17.4% experiencing severe anxiety symptoms. Saudi nationality (OR = 40.15, P = 0.035) was significantly linked to clinical diagnoses. Shorter disease duration (< 6 months, P = 0.017; 1-3 years, P = 0.011), was associated with lower odds of anxiety symptoms, while recent exacerbations (< 3 months, P = 0.012) were associated with increased risk of anxiety symptoms. Higher risk of depression symptoms was associated with recent exacerbations (OR = 7.51, P = 0.055) and smoking (OR = 5.04, P = 0.072). Barriers included stigma (8.7%), cost (6.5%), and concerns about medication side effects (40.2%). Conclusion: The burden of undiagnosed anxiety and depression is significant among IBD patients in Makkah. Routine screening, stigma reduction, and integrated mental health care are essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.